Formulary
Calcium polystyrene sulfonate: Indications, Dosing, Side Effects and Interactions
Calcium polystyrene sulfonate clinical drug profile including indications, dosing, side effects, cautions and interactions.
MedNext Academy | 3 min read
Calcium polystyrene sulfonate: Indications, Dosing, Side Effects and Interactions
Calcium polystyrene sulfonate clinical drug profile including indications, dosing, side effects, cautions and interactions.
Indications and dose
**Hyperkalaemia associated with anuria or severe oliguria, and in dialysis patients**
- **Adult** (By Mouth): 15 g 3-4 times a day.
- **Adult** (By Rectum): 30 g, retained for 9 hours followed by irrigation to remove resin from colon.
**Hyperkalaemia associated with anuria or severe oliguria, and in dialysis patients for calcium polystyrene sulfonate**
- **Child** (By mouth): 0.5-1 g/kg daily in divided doses; maximum 60 g per day.
- **Neonate** (By rectum): 0.5-1 g/kg daily, irrigate colon to remove resin after 8-12 hours.
- **Child** (By rectum): 0.5-1 g/kg daily, irrigate colon to remove resin after 8-12 hours; maximum 30 g per day.
Contraindications
For calcium polystyrene sulfonate Hyperparathyroidism; metastatic carcinoma; multiple myeloma; obstructive bowel disease; sarcoidosis
Side effects
For calcium polystyrene sulfonate Frequency not known Appetite decreased; constipation (discontinue-avoid magnesium-containing laxatives); diarrhoea; electrolyte imbalance; epigastric discomfort; gastrointestinal disorders; gastrointestinal necrosis (in combination with sorbitol); hypercalcaemia (in dialysed patients and occasionally in those with renal impairment); increased risk of infection; nausea; vomiting
Interactions
**Severe interactions:**
- Concomitant use not recommended Sorbitol (oral or rectal): Concomitant use of Sorbitol with calcium polystyrene sulfonate is not recommended due to cases of intestinal necrosis and other serious...
**Other interactions (2):**
- Lithium: Possible decrease of lithium absorption.
- Levothyroxine: Possible decrease of levothyroxine absorption.
Pregnancy
For calcium polystyrene sulfonate Manufacturers advise use only if potential benefit outweighs risk-no information available.
Breast feeding
For calcium polystyrene sulfonate Manufacturers advise use only if potential benefit outweighs risk-no information available.
Medicinal forms
Clinical governance
**Author:** MedNext Clinical Team. **Clinical reviewer:** Dr Shameer Deen, MBBS, MS, MRCS. **Sources:** BNF, Indian Pharmacopoeia, CIMS India. **Correction:** Report errors at support@mednext.academy.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- Growing visual cheat sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Subject HubPharmacology Hub
All pharmacology resources in one place.
Drug SchedulesIndian Drug Schedules
Schedule H, H1, X and G classifications.
FormularyBrowse all drugs
Search 1,850+ drug profiles.
Study Calcium polystyrene sulfonate in the MedNext app
Challenge yourself with targeted pharmacology MCQs on this drug class. Every explanation links back to the chapter that teaches the concept.
Start drug challengeExplore the full formulary

